Dapagliflozin in HFrEF may cut arrhythmias, sudden death: DAPA-HF
Pediatric News ,
Dapagliflozin might reduce the risk for ventricular arrhythmias and sudden death in patients with heart failure and reduced…
Dapagliflozin in HFrEF May Cut Arrhythmias, Sudden Death: DAPA-HF
Medscape,
Dapagliflozin might reduce the risk for ventricular arrhythmias and sudden death in patients with heart failure and reduced…
Diminished Cardiac Arrhythmia Risk Linked With Sodium Glucose Cotransporter Inhibitors
U.S.Pharmacist,
In a study published in Cardiovascular Diabetology, Hang-Long et al searched the MEDLINE, EMBASE, and ClinicalTrials.gov…
SGLT2i Use Linked to Reduced Cardiac Arrhythmia Risk
Endocrinology Advisor,
Sodium-glucose cotransporter 2 inhibitors (SGLT2i) use may reduce cardiac arrhythmia risk and should be considered for use in…